tiprankstipranks
ENDRA Life Sciences Inc (NDRA)
NASDAQ:NDRA
US Market

ENDRA Life Sciences (NDRA) Income Statement

Compare
788 Followers

ENDRA Life Sciences Income Statement

Last quarter (Q3 2024), ENDRA Life Sciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, ENDRA Life Sciences's net income was $-2.35M. See ENDRA Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -275.45K$ -234.26K$ -224.41K$ -165.25K$ -115.01K
Operating Expenses
$ 10.52M$ 13.16M$ 11.50M$ 11.50M$ 10.84M
Depreciation and Amortization
$ 275.45K$ 234.26K$ 224.41K$ 165.25K$ 115.01K
EBITDA
$ -9.78M$ -12.94M$ -11.01M$ -11.33M$ -10.84M
Operating Income
$ -10.52M$ -13.16M$ -11.50M$ -11.50M$ -10.84M
Other Income/Expenses
$ 460.49K$ -21.53K$ 267.06K$ -223.58K$ -2.46M
Pretax Income
$ -10.06M$ -13.18M$ -11.23M$ -11.73M$ -13.31M
Net Income
$ -10.06M$ -13.20M$ -11.19M$ -11.97M$ -15.55M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.11$ -4.57$ -5.47$ -12.47$ -41.48
Diluted EPS
$ -1.11$ -4.57$ -5.47$ -12.47$ -41.48
Weighted Average Shares Outstanding
9.04M 2.89M 2.05M 959.61K 375.00K
Weighted Average Shares Outstanding (Diluted)
9.04M 2.89M 2.05M 959.61K 375.00K
Currency in USD

ENDRA Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis